共 50 条
- [4] Long-term evaluation (efficacy and safety) of infliximab in the treatment of persistently active juvenile idiopathic arthritis (JIA), refractory to standard treatments. [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S84 - S84
- [9] Infliximab in the treatment of refractory juvenile idiopathic arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S481 - S481